Published in Clin Nephrol on December 27, 2016
The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int (2009) 7.45
The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int (2009) 7.19
Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys (2009) 6.11
Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol (2011) 4.12
Remission of proteinuria improves prognosis in IgA nephropathy. J Am Soc Nephrol (2007) 3.66
Immunostaining findings in IgA nephropathy: correlation with histology and clinical outcome in the Oxford classification patient cohort. Nephrol Dial Transplant (2011) 2.51
The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults. Kidney Int (2010) 2.14
A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment. Breast Cancer Res (2003) 2.09
RTOG sarcoma radiation oncologists reach consensus on gross tumor volume and clinical target volume on computed tomographic images for preoperative radiotherapy of primary soft tissue sarcoma of extremity in Radiation Therapy Oncology Group studies. Int J Radiat Oncol Biol Phys (2011) 2.06
Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro Oncol (2013) 1.88
Pentastarch 10% (250 kDa/0.45) is an independent risk factor of acute kidney injury following cardiac surgery. Crit Care Med (2009) 1.76
Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases. Int J Radiat Oncol Biol Phys (2011) 1.74
Enalapril reduces the incidence of diabetes in patients with chronic heart failure: insight from the Studies Of Left Ventricular Dysfunction (SOLVD). Circulation (2003) 1.69
Intensity-modulated radiotherapy for craniospinal irradiation: target volume considerations, dose constraints, and competing risks. Int J Radiat Oncol Biol Phys (2007) 1.64
Standard and nonstandard craniospinal radiotherapy using helical TomoTherapy. Int J Radiat Oncol Biol Phys (2010) 1.55
Validation of the Oxford classification of IgA nephropathy. Kidney Int (2011) 1.53
A multicenter application and evaluation of the oxford classification of IgA nephropathy in adult chinese patients. Am J Kidney Dis (2012) 1.32
Have we changed the outcome in membranous nephropathy? A propensity study on the role of immunosuppressive therapy. Clin J Am Soc Nephrol (2011) 1.18
Evaluation of the Oxford Classification of IgA nephropathy: a systematic review and meta-analysis. Am J Kidney Dis (2013) 1.17
The impact of sex in primary glomerulonephritis. Nephrol Dial Transplant (2008) 1.14
Oxidative stress and galactose-deficient IgA1 as markers of progression in IgA nephropathy. Clin J Am Soc Nephrol (2011) 1.14
Accelerated hypofractionated intensity-modulated radiotherapy with concurrent and adjuvant temozolomide for patients with glioblastoma multiforme: a safety and efficacy analysis. Int J Radiat Oncol Biol Phys (2008) 1.08
Preponderance of sonic hedgehog pathway activation characterizes adult medulloblastoma. Acta Neuropathol (2010) 0.97
Variation in the gross tumor volume and clinical target volume for preoperative radiotherapy of primary large high-grade soft tissue sarcoma of the extremity among RTOG sarcoma radiation oncologists. Int J Radiat Oncol Biol Phys (2011) 0.96
Adherence to antihypertensive agents improves risk reduction of end-stage renal disease. Kidney Int (2013) 0.96
Canadian Society of Nephrology commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD. Am J Kidney Dis (2013) 0.95
Characteristics and outcomes of medulloblastoma in adults. Pediatr Blood Cancer (2008) 0.94
Lymphopenia and treatment-related infectious complications in ANCA-associated vasculitis. Clin J Am Soc Nephrol (2012) 0.94
The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer. J Neurooncol (2013) 0.94
Predictive parameters of CyberKnife fiducial-less (XSight Lung) applicability for treatment of early non-small cell lung cancer: a single-center experience. Int J Radiat Oncol Biol Phys (2013) 0.90
Agreement among RTOG sarcoma radiation oncologists in contouring suspicious peritumoral edema for preoperative radiation therapy of soft tissue sarcoma of the extremity. Int J Radiat Oncol Biol Phys (2013) 0.89
Prophylactic cranial irradiation in advanced breast cancer: a case for caution. Int J Radiat Oncol Biol Phys (2008) 0.89
Rotational total skin electron irradiation with a linear accelerator. J Appl Clin Med Phys (2008) 0.88
Waldenstrom's macroglobulinemia presenting with spinal cord compression: a case report. Am J Hematol (2006) 0.87
Cardiac embolization of an implanted fiducial marker for hepatic stereotactic body radiotherapy: a case report. J Med Case Rep (2009) 0.86
Clinical value of inflammatory urinary biomarkers in overt diabetic nephropathy: a prospective study. Diabetes Res Clin Pract (2013) 0.86
Validating the oxford classification of IgA nephropathy. Clin J Am Soc Nephrol (2011) 0.85
Stereotactic radiosurgery in the management of brain metastases from primary thyroid cancers. J Neurooncol (2010) 0.85
To treat or not to treat, that is the question: proceedings of the Quebec symposium for the treatment of osteoporosis in long-term care institutions, Saint-Hyacinthe, Quebec, November 5, 2004. J Am Med Dir Assoc (2007) 0.85
Implanting metal fiducials to guide stereotactic liver radiation: McGill experience and review of current devices, techniques and complications. Technol Cancer Res Treat (2013) 0.83
Carbamazepine poisoning treated by multiple extracorporeal treatments. Clin Nephrol (2015) 0.82
Low-grade oligodendroglioma: an indolent but incurable disease? Clinical article. J Neurosurg (2009) 0.82
PET/CT for radiotherapy treatment planning in patients with soft tissue sarcomas. Int J Radiat Oncol Biol Phys (2009) 0.81
Acute Kidney Injury and Renal Recovery with the Use of Aminoglycosides: A Large Retrospective Study. Nephron (2015) 0.81
Preoperative intensity modulated radiation therapy for retroperitoneal sarcoma. Technol Cancer Res Treat (2013) 0.81
Prevalence, awareness, and management of CKD and cardiovascular risk factors in publicly funded health care. Clin J Am Soc Nephrol (2014) 0.81
Metabolic activity measured on PET/CT correlates with clinical outcomes in patients with limb and girdle sarcomas. J Surg Oncol (2013) 0.81
Local recurrence after initial multidisciplinary management of soft tissue sarcoma: is there a way out? Clin Orthop Relat Res (2010) 0.81
Soluble Fas is a marker of peripheral arterial occlusive disease in haemodialysis patients. Nephrol Dial Transplant (2002) 0.80
Current standards in the management of cerebral metastases. Int J Surg Oncol (2011) 0.79
Urinary monocyte chemotactic protein 1: marker of renal function decline in diabetic and nondiabetic proteinuric renal disease. J Nephrol (2010) 0.79
Stereotactic radiotherapy of the liver: a bridge to transplantation stereotactic radiotherapy of the liver: a bridge to transplantation. Technol Cancer Res Treat (2009) 0.78
Tonsillectomy in a European Cohort of 1,147 Patients with IgA Nephropathy. Nephron (2015) 0.78
Pathophysiology of chronic kidney disease-mineral and bone disorder. Joint Bone Spine (2012) 0.78
To treat or not to treat, that is the question: proceedings of the Quebec Symposium for the Treatment of Osteoporosis in Long-term Care Institutions, Saint-Hyacinthe, Quebec, November 5, 2004. J Am Med Dir Assoc (2006) 0.77
When temozolomide alone fails: adding procarbazine in salvage therapy of glioma. Can J Neurol Sci (2008) 0.77
Measurement of the international normalized ratio (INR) in hemodialysis patients with heparin-locked central venous catheters: evaluation of a novel blood sampling method. J Vasc Access (2009) 0.77
Comparison of oral and intravenous alfacalcidol in chronic hemodialysis patients. BMC Nephrol (2014) 0.76
A comparison of optic nerve dosimetry in craniospinal radiotherapy planned and treated with conventional and intensity modulated techniques. Radiother Oncol (2010) 0.76
Authors' response. Crit Care (2015) 0.75
Skin elasticity as a measure of radiation fibrosis: is it reproducible and does it correlate with patient and physician-reported measures? Technol Cancer Res Treat (2013) 0.75
The effect of sodium citrate 4% locking solution for central venous dialysis catheter on the international normalized ratio (INR) value. Nephrol Dial Transplant (2008) 0.75
In reply to Prabhu et Al. Int J Radiat Oncol Biol Phys (2012) 0.75
Incidence and Severity of Lymphoedema following Limb Salvage of Extremity Soft Tissue Sarcoma. Sarcoma (2011) 0.75
Authors’ response. Crit Care (2015) 0.75
In Reply to O'Sullivan et al. Int J Radiat Oncol Biol Phys (2012) 0.75
In regard to Yamamoto et al. Int J Radiat Oncol Biol Phys (2012) 0.75
Uric acid association with pulsatile and steady components of central and peripheral blood pressures. J Hypertens (2017) 0.75
Effects of neurosurgical titanium mesh on radiation dose. Med Dosim (2006) 0.75
Heart rate dependent and independent effects of beta-blockers on central hemodynamic parameters: a propensity score analysis. J Hypertens (2016) 0.75
Gene polymorphisms as clinical tools in chronic glomerulopathies: a prospective study. Nephron Clin Pract (2013) 0.75
Late radiation toxicity in Hodgkin lymphoma patients: proton therapy's potential. J Appl Clin Med Phys (2015) 0.75
Necrosis following skull base irradiation and stem cell transplant for multiple myeloma. Am J Hematol (2010) 0.75